BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 3753607)

  • 1. Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus.
    Gething MJ; Doms RW; York D; White J
    J Cell Biol; 1986 Jan; 102(1):11-23. PubMed ID: 3753607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant influenza virus hemagglutinin that induces fusion at elevated pH.
    Doms RW; Gething MJ; Henneberry J; White J; Helenius A
    J Virol; 1986 Feb; 57(2):603-13. PubMed ID: 3003392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the fusion peptide sequence in initial stages of influenza hemagglutinin-induced cell fusion.
    Schoch C; Blumenthal R
    J Biol Chem; 1993 May; 268(13):9267-74. PubMed ID: 8387488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid substitution at position 226 of the hemagglutinin molecule of influenza (H1N1) virus affects receptor binding activity but not fusion activity.
    Nobusawa E; Nakajima K
    Virology; 1988 Nov; 167(1):8-14. PubMed ID: 2460997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
    Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
    Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of acidic residues in the "fusion segment" of influenza A virus hemagglutinin in low-pH-dependent membrane fusion.
    Nobusawa E; Hishida R; Murata M; Kawasaki K; Ohnishi S; Nakajima K
    Arch Virol; 1995; 140(5):865-75. PubMed ID: 7605199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles.
    Steinhauer DA; Wharton SA; Skehel JJ; Wiley DC; Hay AJ
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11525-9. PubMed ID: 1763066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
    Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
    J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Glu11 and Gly8 of the H5N1 influenza hemagglutinin fusion peptide in membrane fusion using pseudotype virus and reverse genetics.
    Su Y; Zhu X; Wang Y; Wu M; Tien P
    Arch Virol; 2008; 153(2):247-57. PubMed ID: 18030546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the hemagglutinin gene of the neurovirulent influenza virus strain A/NWS/33.
    Ward AC; de Koning-Ward TF
    Virus Genes; 1995; 10(2):179-83. PubMed ID: 8560778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin.
    Steinhauer DA; Wharton SA; Skehel JJ; Wiley DC
    J Virol; 1995 Nov; 69(11):6643-51. PubMed ID: 7474073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no effect on membrane fusion properties.
    Steinhauer DA; Wharton SA; Wiley DC; Skehel JJ
    Virology; 1991 Sep; 184(1):445-8. PubMed ID: 1871979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
    Brassard DL; Lamb RA
    Virology; 1997 Sep; 236(2):234-48. PubMed ID: 9325231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity.
    Simpson DA; Lamb RA
    J Virol; 1992 Feb; 66(2):790-803. PubMed ID: 1309913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin.
    Vanderlinden E; Göktas F; Cesur Z; Froeyen M; Reed ML; Russell CJ; Cesur N; Naesens L
    J Virol; 2010 May; 84(9):4277-88. PubMed ID: 20181685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza hemagglutinin (HA) stem region mutations that stabilize or destabilize the structure of multiple HA subtypes.
    Byrd-Leotis L; Galloway SE; Agbogu E; Steinhauer DA
    J Virol; 2015 Apr; 89(8):4504-16. PubMed ID: 25653452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane fusion activity of the influenza virus hemagglutinin: interaction of HA2 N-terminal peptides with phospholipid vesicles.
    Rafalski M; Ortiz A; Rockwell A; van Ginkel LC; Lear JD; DeGrado WF; Wilschut J
    Biochemistry; 1991 Oct; 30(42):10211-20. PubMed ID: 1931950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H+-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region.
    Durrer P; Galli C; Hoenke S; Corti C; Glück R; Vorherr T; Brunner J
    J Biol Chem; 1996 Jun; 271(23):13417-21. PubMed ID: 8662770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acylation of the influenza hemagglutinin modulates fusion activity.
    Fischer C; Schroth-Diez B; Herrmann A; Garten W; Klenk HD
    Virology; 1998 Sep; 248(2):284-94. PubMed ID: 9721237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 1-127 HA2 construct of influenza virus hemagglutinin induces cell-cell hemifusion.
    Leikina E; LeDuc DL; Macosko JC; Epand R; Epand R; Shin YK; Chernomordik LV
    Biochemistry; 2001 Jul; 40(28):8378-86. PubMed ID: 11444985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.